Mic Capital Management Uk LLP Eq Rx, Inc. Transaction History

Mic Capital Management Uk LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.66 - $2.31 $4.15 Million - $5.78 Million	-2,500,000 Reduced 35.34%	4,573,470 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $4.3 Million - $27.4 Million	4,573,470 Added 182.94%	7,073,470 $35 Million
Q4 2021 Feb 14, 2022	BUY	$5.92 - $9.98 $14.8 Million - $25 Million	2,500,000 New	2,500,000 $17.1 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Mic Capital Management Uk LLP, based on Form 13F filings with the SEC.

Stay updated on Mic Capital Management Uk LLP with notifications on news.